Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Otorhinolaryngology

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    March 2017
  1. LIGTENBERG H, Jager EA, Caldas-Magalhaes J, Schakel T, et al
    Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI.
    Radiother Oncol. 2017 Mar 1. pii: S0167-8140(17)30064.
    PubMed     Text format     Abstract available


    February 2017
  2. ZSCHAECK S, Lock S, Leger S, Haase R, et al
    FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
    Radiother Oncol. 2017 Feb 17. pii: S0167-8140(17)30047.
    PubMed     Text format     Abstract available


    January 2017
  3. PATEL R, Barker HE, Kyula J, McLaughlin M, et al
    An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
    Radiother Oncol. 2017 Jan 25. pii: S0167-8140(16)34478.
    PubMed     Text format     Abstract available


  4. FUCCIO L, Mandolesi D, Farioli A, Hassan C, et al
    Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.
    Radiother Oncol. 2017 Jan 16. pii: S0167-8140(17)30003.
    PubMed     Text format     Abstract available


    November 2016
  5. THOR M, Owosho AA, Clark HD, Oh JH, et al
    Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.
    Radiother Oncol. 2016 Nov 24. pii: S0167-8140(16)34380.
    PubMed     Text format     Abstract available


  6. LESZCZYNSKA KB, Dobrynin G, Leslie RE, Ient J, et al
    Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer.
    Radiother Oncol. 2016 Nov 10. pii: S0167-8140(16)34372.
    PubMed     Text format     Abstract available


  7. WANG L, Liu L, Han C, Liu S, et al
    The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Radiother Oncol. 2016 Nov 9. pii: S0167-8140(16)34370.
    PubMed     Text format     Abstract available


    October 2016
  8. QIU B, Wang D, Yang H, Xie W, et al
    Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
    Radiother Oncol. 2016 Oct 25. pii: S0167-8140(16)34352.
    PubMed     Text format     Abstract available


  9. MARTINEZ-FERNANDEZ MI, Alcalde J, Cambeiro M, Peydro GV, et al
    Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.
    Radiother Oncol. 2016 Oct 13. pii: S0167-8140(16)34287.
    PubMed     Text format     Abstract available


    August 2016
  10. HE L, Chapple A, Liao Z, Komaki R, et al
    Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.
    Radiother Oncol. 2016 Aug 22. pii: S0167-8140(16)31243.
    PubMed     Text format     Abstract available


  11. NEVENS D, Duprez F, Daisne JF, Dok R, et al
    Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.
    Radiother Oncol. 2016 Aug 12. pii: S0167-8140(16)34247.
    PubMed     Text format     Abstract available


  12. CHUTER R, Prestwich R, Bird D, Scarsbrook A, et al
    The use of deformable image registration to integrate diagnostic MRI into the radiotherapy planning pathway for head and neck cancer.
    Radiother Oncol. 2016 Aug 3. pii: S0167-8140(16)31212.
    PubMed     Text format     Abstract available


    July 2016
  13. LOIMU V, Seppala T, Kapanen M, Tuomikoski L, et al
    Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Radiother Oncol. 2016 Jul 27. pii: S0167-8140(16)31200.
    PubMed     Text format     Abstract available


  14. WONG KH, Kuciejewska A, Sharabiani MT, Ng-Cheng-Hin B, et al
    A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.
    Radiother Oncol. 2016 Jul 5. pii: S0167-8140(16)31174.
    PubMed     Text format     Abstract available


    June 2016
  15. BROUWER CL, Steenbakkers RJ, van der Schaaf A, Sopacua CT, et al
    Selection of head and neck cancer patients for adaptive radiotherapy to decrease xerostomia.
    Radiother Oncol. 2016 Jun 23. pii: S0167-8140(16)31149.
    PubMed     Text format     Abstract available


  16. LIN P, Min M, Lee M, Holloway L, et al
    Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
    Radiother Oncol. 2016 Jun 16. pii: S0167-8140(16)31124.
    PubMed     Text format     Abstract available


  17. MATUSCHEK C, Bolke E, Geigis C, Kammers K, et al
    Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients.
    Radiother Oncol. 2016 Jun 10. pii: S0167-8140(16)31120.
    PubMed     Text format     Abstract available


    May 2016
  18. CHEN CY, Li CC, Chien CR
    Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.
    Radiother Oncol. 2016 May 17. pii: S0167-8140(16)31089.
    PubMed     Text format     Abstract available


  19. KJAER T, Dalton SO, Andersen E, Karlsen R, et al
    A controlled study of use of patient-reported outcomes to improve assessment of late effects after treatment for head-and-neck cancer.
    Radiother Oncol. 2016 May 10. pii: S0167-8140(16)31080.
    PubMed     Text format     Abstract available


  20. JANSSENS GO, Langendijk JA, Terhaard CH, Doornaert PA, et al
    Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck Society.
    Radiother Oncol. 2016 May 7. pii: S0167-8140(16)00111.
    PubMed     Text format     Abstract available


    April 2016
  21. TOL JP, Doornaert P, Witte BI, Dahele M, et al
    A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients.
    Radiother Oncol. 2016 Apr 26. pii: S0167-8140(16)31045.
    PubMed     Text format     Abstract available


  22. MOSLEMI D, Nokhandani AM, Otaghsaraei MT, Moghadamnia Y, et al
    Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
    Radiother Oncol. 2016 Apr 21. pii: S0167-8140(16)31035.
    PubMed     Text format     Abstract available


  23. PALMA B, Bazalova-Carter M, Hardemark B, Hynning E, et al
    Assessment of the quality of very high-energy electron radiotherapy planning.
    Radiother Oncol. 2016;119:154-8.
    PubMed     Text format     Abstract available


    March 2016
  24. MACFARLANE M, Hoover DA, Wong E, Read N, et al
    Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
    Radiother Oncol. 2016 Mar 31. pii: S0167-8140(16)31017.
    PubMed     Text format     Abstract available


  25. ELICIN O, Nisa L, Dal Pra A, Bojaxhiu B, et al
    Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.
    Radiother Oncol. 2016 Mar 17. pii: S0167-8140(16)00125.
    PubMed     Text format     Abstract available


  26. RASMUSSEN JH, Hakansson K, Vogelius IR, Aznar MC, et al
    Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
    Radiother Oncol. 2016 Mar 15. pii: S0167-8140(16)00127.
    PubMed     Text format     Abstract available


  27. HATTON MQ, Hill R, Fenwick JD, Morgan SA, et al
    Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I study.
    Radiother Oncol. 2016;118:471-7.
    PubMed     Text format     Abstract available


  28. JANSSENS G, Smeets J, Vander Stappen F, Prieels D, et al
    Sensitivity study of prompt gamma imaging of scanned beam proton therapy in heterogeneous anatomies.
    Radiother Oncol. 2016;118:562-7.
    PubMed     Text format     Abstract available


    February 2016
  29. CHENG Q, Roelofs E, Ramaekers BL, Eekers D, et al
    Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - Comparison of dose, toxicity and cost-effectiveness.
    Radiother Oncol. 2016 Feb 26. pii: S0167-8140(16)00031.
    PubMed     Text format     Abstract available


  30. HONG A, Zhang X, Jones D, Veillard AS, et al
    Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2016;118:342-9.
    PubMed     Text format     Abstract available



  31. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    Radiother Oncol. 2016;118:304-14.
    PubMed     Text format     Abstract available


  32. LYHNE NM, Johansen J, Kristensen CA, Andersen E, et al
    Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.
    Radiother Oncol. 2016;118:257-66.
    PubMed     Text format     Abstract available


  33. LEE JY, Sun JM, Oh DR, Lim SH, et al
    Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).
    Radiother Oncol. 2016;118:244-50.
    PubMed     Text format     Abstract available


  34. ZENDA S, Akimoto T, Mizumoto M, Hayashi R, et al
    Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses.
    Radiother Oncol. 2016;118:267-71.
    PubMed     Text format     Abstract available


    January 2016
  35. MESSER JA, Mohamed AS, Hutcheson KA, Ding Y, et al
    Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Radiother Oncol. 2016 Jan 28. pii: S0167-8140(16)00033.
    PubMed     Text format     Abstract available


  36. NYQVIST J, Fransson P, Laurell G, Hammerlid E, et al
    Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
    Radiother Oncol. 2016 Jan 6. pii: S0167-8140(15)00685.
    PubMed     Text format     Abstract available


    December 2015
  37. KHAN Z, Khan AA, Prasad GB, Khan N, et al
    Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Radiother Oncol. 2015 Dec 30. pii: S0167-8140(15)00665.
    PubMed     Text format     Abstract available


  38. DE FELICE F, Musio D, Tombolini V
    Mastication structures definition in head and neck cancer.
    Radiother Oncol. 2015 Dec 29. pii: S0167-8140(15)00677.
    PubMed     Text format    


  39. TAWK B, Schwager C, Deffaa O, Dyckhoff G, et al
    Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Radiother Oncol. 2015 Dec 19. pii: S0167-8140(15)00647.
    PubMed     Text format     Abstract available


  40. CHRISTIANEN ME, van der Schaaf A, van der Laan HP, Verdonck-de Leeuw IM, et al
    Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.
    Radiother Oncol. 2015 Dec 14. pii: S0167-8140(15)00613.
    PubMed     Text format     Abstract available


    November 2015
  41. MOON H, Roh JL, Lee SW, Kim SB, et al
    Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Radiother Oncol. 2015 Nov 30. pii: S0167-8140(15)00597.
    PubMed     Text format     Abstract available


  42. BUDACH W, Bolke E, Kammers K, Gerber PA, et al
    Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Radiother Oncol. 2015 Nov 14. pii: S0167-8140(15)00563.
    PubMed     Text format     Abstract available


    October 2015
  43. NEVENS D, Deschuymer S, Langendijk JA, Daisne JF, et al
    Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and a partially accelerated radiotherapy scheme.
    Radiother Oncol. 2015 Oct 15. pii: S0167-8140(15)00550.
    PubMed     Text format     Abstract available


  44. DE BREE R, van der Putten L, van Tinteren H, Wedman J, et al
    Effectiveness of an F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    Radiother Oncol. 2015 Oct 15. pii: S0167-8140(15)00552.
    PubMed     Text format     Abstract available


    July 2015
  45. SAMUELS SE, Vainshtein J, Spector ME, Ibrahim M, et al
    Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.
    Radiother Oncol. 2015;116:75-81.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: